The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Agios Pharmaceuticals Inc shares valued at $162,464 were sold by Gheuens Sarah on Jul 01 ’24. At $43.85 per share, Gheuens Sarah sold 3,705 shares. The insider’s holdings dropped to 43,736 shares worth approximately $1.84 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Goff Brian sold 12,115 shares, netting a total of over 591,697 in proceeds. Following the sale of shares at $48.84 each, the insider now holds 67,192 shares.
Before that, Washburn Theodore James Jr. had sold 1,362 shares from its account. In a trade valued at $60,459, the Principal Accounting Officer traded Agios Pharmaceuticals Inc shares for $44.39 each. Upon closing the transaction, the insider’s holdings decreased to 1,362 shares, worth approximately $64038.48.
As published in their initiating research note from Cantor Fitzgerald on February 08, 2024, Agios Pharmaceuticals Inc [AGIO] has been an Overweight. Analysts at Piper Sandler started covering the stock with ‘”an Overweight”‘ outlook in a report released in early February. As of November 17, 2022, Goldman has increased its “Sell” rating to a “Neutral” for AGIO. Earlier on July 27, 2022, SVB Leerink upgraded its rating. Their new recommendation was “an Outperform” for AGIO stock which previously was a “a Mkt perform”.
Analyzing AGIO Stock Performance
During the last five days, there has been a drop of approximately -3.09%. Over the course of the year, Agios Pharmaceuticals Inc shares have jumped approximately 88.68%. Shares of the company reached a 52-week high of $49.06 on 06/05/24 and a 52-week low of $20.96 on 01/19/24. A 50-day SMA is recorded $38.72, while a 200-day SMA reached $28.47. Nevertheless, trading volume fell to 0.19 million shares from 0.43 million shares the previous day.
Support And Resistance Levels for Agios Pharmaceuticals Inc (AGIO)
According to the 24-hour chart, there is a support level at 41.52, which, if violated, would cause prices to drop to 41.03. In the upper region, resistance lies at 42.58. The next price resistance is at 43.15. RSI (Relative Strength Index) is 49.26 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.17, which suggests the price will decrease in the coming days. Percent R is at 92.94%, indicating bearish price movement. Stochastics%K at buying indicates that the stock is to be held.
